Literature DB >> 17594131

Racial and socioeconomic disparities in bone density testing before and after hip fracture.

Joan M Neuner1, Xu Zhang, Rodney Sparapani, Purushottam W Laud, Ann B Nattinger.   

Abstract

BACKGROUND: Racial and socioeconomic disparities have been identified in osteoporosis screening.
OBJECTIVE: To determine whether racial and socioeconomic disparities in osteoporosis screening diminish after hip fracture.
DESIGN: Retrospective cohort study of female Medicare patients.
SETTING: Entire states of Illinois, New York, and Florida. PARTICIPANTS: Female Medicare recipients aged 65-89 years old with hip fractures between January 2001 and June 2003. MEASUREMENTS: Differences in bone density testing by race/ethnicity and zip-code level socioeconomic characteristics during the 2-year period preceding and the 6-month period following a hip fracture.
RESULTS: Among all 35,681 women with hip fractures, 20.7% underwent bone mineral density testing in the 2 years prior to fracture and another 6.2% underwent testing in the 6 months after fracture. In a logistic regression model adjusted for age, state, and comorbidity, women of black race were about half as likely (RR 0.52 [0.43, 0.62]) and Hispanic women about 2/3 as likely (RR 0.66 [0.54, 0.80]) as white women to undergo testing before their fracture. They remained less likely (RR 0.66 [0.50, 0.88] and 0.58 [0.39, 0.87], respectively) to undergo testing after fracture. In contrast, women residing in zip codes in the lowest tertile of income and education were less likely than those in higher-income and educational tertiles to undergo testing before fracture, but were no less likely to undergo testing in the 6 months after fracture.
CONCLUSIONS: Racial, but not socioeconomic, differences in osteoporosis evaluation continued to occur even after Medicare patients had demonstrated their propensity to fracture. Future interventions may need to target racial/ethnic and socioeconomic disparities differently.

Entities:  

Mesh:

Year:  2007        PMID: 17594131      PMCID: PMC2219762          DOI: 10.1007/s11606-007-0217-1

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  31 in total

1.  Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology.

Authors:  N Krieger
Journal:  Am J Public Health       Date:  1992-05       Impact factor: 9.308

2.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

3.  Use of census-based aggregate variables to proxy for socioeconomic group: evidence from national samples.

Authors:  A T Geronimus; J Bound
Journal:  Am J Epidemiol       Date:  1998-09-01       Impact factor: 4.897

4.  What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes.

Authors:  J Zhang; K F Yu
Journal:  JAMA       Date:  1998-11-18       Impact factor: 56.272

Review 5.  Integrated care pathways.

Authors:  H Campbell; R Hotchkiss; N Bradshaw; M Porteous
Journal:  BMJ       Date:  1998-01-10

6.  Race and sex differences in mortality following fracture of the hip.

Authors:  S J Jacobsen; J Goldberg; T P Miles; J A Brody; W Stiers; A A Rimm
Journal:  Am J Public Health       Date:  1992-08       Impact factor: 9.308

7.  Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

Authors:  S T Harris; N B Watts; H K Genant; C D McKeever; T Hangartner; M Keller; C H Chesnut; J Brown; E F Eriksen; M S Hoseyni; D W Axelrod; P D Miller
Journal:  JAMA       Date:  1999-10-13       Impact factor: 56.272

8.  Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

Authors:  U A Liberman; S R Weiss; J Bröll; H W Minne; H Quan; N H Bell; J Rodriguez-Portales; R W Downs; J Dequeker; M Favus
Journal:  N Engl J Med       Date:  1995-11-30       Impact factor: 91.245

9.  Risk factors for hip fracture in black women. The Northeast Hip Fracture Study Group.

Authors:  J A Grisso; J L Kelsey; B L Strom; L A O'Brien; G Maislin; K LaPann; L Samelson; S Hoffman
Journal:  N Engl J Med       Date:  1994-06-02       Impact factor: 91.245

10.  Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.

Authors:  S R Cummings; D M Black; D E Thompson; W B Applegate; E Barrett-Connor; T A Musliner; L Palermo; R Prineas; S M Rubin; J C Scott; T Vogt; R Wallace; A J Yates; A Z LaCroix
Journal:  JAMA       Date:  1998 Dec 23-30       Impact factor: 56.272

View more
  27 in total

1.  The impact of substance abuse on osteoporosis screening and risk of osteoporosis in women with psychotic disorders.

Authors:  D L Kelly; C S Myers; M T Abrams; S Feldman; J Park; R P McMahon; J-C Shim
Journal:  Osteoporos Int       Date:  2010-06-09       Impact factor: 4.507

2.  Physician tiering by health plans in Massachusetts.

Authors:  Ajay D Wadgaonkar; Eric C Schneider; Timothy Bhattacharyya
Journal:  J Bone Joint Surg Am       Date:  2010-09-15       Impact factor: 5.284

3.  Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients.

Authors:  J M Neuner; T W Yen; R A Sparapani; P W Laud; A B Nattinger
Journal:  Osteoporos Int       Date:  2010-12-18       Impact factor: 4.507

Review 4.  The association between socioeconomic status and osteoporotic fracture in population-based adults: a systematic review.

Authors:  S L Brennan; J A Pasco; D M Urquhart; B Oldenburg; F Hanna; A E Wluka
Journal:  Osteoporos Int       Date:  2008-12-24       Impact factor: 4.507

5.  Is lower income associated with an increased likelihood of qualification for treatment for osteoporosis in Canadian women?

Authors:  S L Brennan; W D Leslie; L M Lix
Journal:  Osteoporos Int       Date:  2013-08-02       Impact factor: 4.507

6.  Effect of self-referral on bone mineral density testing and osteoporosis treatment.

Authors:  Amy H Warriner; Ryan C Outman; Adrianne C Feldstein; Douglas W Roblin; Jeroan J Allison; Jeffrey R Curtis; David T Redden; Mary M Rix; Brandi E Robinson; Ana G Rosales; Monika M Safford; Kenneth G Saag
Journal:  Med Care       Date:  2014-08       Impact factor: 2.983

7.  Race Plays a Role in the Knowledge, Attitudes, and Beliefs of Women with Osteoporosis.

Authors:  Nicole C Wright; Mary E Melton; Maira Sohail; Ivan Herbey; Susan Davies; Emily B Levitan; Kenneth G Saag; Natalia V Ivankova
Journal:  J Racial Ethn Health Disparities       Date:  2019-02-11

Review 8.  Association between socioeconomic status and bone mineral density in adults: a systematic review.

Authors:  S L Brennan; J A Pasco; D M Urquhart; B Oldenburg; Y Wang; A E Wluka
Journal:  Osteoporos Int       Date:  2010-05-07       Impact factor: 4.507

9.  Quality of osteoporosis care of older Medicare recipients with fragility fractures: 2006 to 2010.

Authors:  Stephen K Liu; Jeffrey C Munson; John-Erik Bell; Rebecca L Zaha; John N Mecchella; Anna N A Tosteson; Nancy E Morden
Journal:  J Am Geriatr Soc       Date:  2013-10-28       Impact factor: 5.562

10.  Bone mass in schoolchildren in Brazil: the effect of racial miscegenation, pubertal stage, and socioeconomic differences.

Authors:  Roberto Regis Ribeiro; Gil Guerra-Junior; Antonio de Azevedo Barros-Filho
Journal:  J Bone Miner Metab       Date:  2009-03-13       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.